E. van Munster

Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

J. Lechner-Scott, M. Slee, J. Correale, 2013, PloS one.

Contribution of different relapse phenotypes to disability in multiple sclerosis

Pierre Grammond, Patrizia Sola, Fraser Moore, 2017, Multiple sclerosis.

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Pierre Grammond, Patrick McElduff, Guillermo Izquierdo, 2015, PloS one.

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Three distinct physical behavior types in fatigued patients with multiple sclerosis

H. Stam, G. Kwakkel, G. Bleijenberg, 2019, Journal of NeuroEngineering and Rehabilitation.

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

F. Barkhof, C. Polman, B. V. van Oosten, 2011, Neurology.

Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?

F. Barkhof, M. Wattjes, J. V. van Eijk, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

SSEP chronotopography in patients with multiple sclerosis

O. Hommes, E. Colon, E. van Munster, 1984, Acta neurologica Scandinavica.